Search This Blog

Tuesday, August 6, 2019

Jazz Pharmaceuticals EPS beats by $0.48, beats on revenue

Jazz Pharmaceuticals (NASDAQ:JAZZ): Q2 Non-GAAP EPS of $4.05 beats by $0.48; GAAP EPS of $4.45 beats by $3.73.
Revenue of $534.13M (+6.7% Y/Y) beats by $26.9M.
Shares +0.5%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)